CHUGAI PHARMACEUTICAL CO., LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,852 JPY | -0.16% |
|
-1.40% | -9.17% |
| Apr. 25 | Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% | MT |
| Apr. 24 | Chugai Pharmaceutical's Profit Slightly Up in Q1 | MT |
Presenter SpeechOsamu Okuda (Executives)Welcome to our conference call. I am Osama Okuda, Pres...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).
Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).
Sector
Pharmaceuticals
Calendar
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,860
JPY
Average target price
6,044
JPY
Spread / Average Target
+24.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -9.17% | 51.41B | |
| +25.04% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.02% | 233B | |
| +5.26% | 201B | |
| -10.27% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
- Stock Market
- Equities
- 4519 Stock
- News Chugai Pharmaceutical Co., Ltd
- Transcript : Chugai Pharmaceutical Co., Ltd., Q1 2021 Earnings Call, Apr 22, 2021
